School of Pharmacy, College of Life and Environmental Science, Minzu University of China, Beijing, 100081, China.
School of Pharmacy, North China University of Science and Technology, Tangshan, 063210, China.
J Nanobiotechnology. 2024 Nov 13;22(1):704. doi: 10.1186/s12951-024-02907-5.
As novel multifunctional materials that merge enzyme-like capabilities with the distinctive traits of nanomaterials, nanozymes have made significant strides in interdisciplinary research areas spanning materials science, bioscience, and beyond. This article, for the first time, employed bibliometric methods to conduct an in-depth statistical analysis of the global nanozymes research and demonstrate research progress, hotspots and trends. Drawing on data from the Web of Science Core Collection database, we comprehensively retrieved the publications from 2004 to 2024. The burgeoning interest in nanozymes research across various nations indicated a growing and widespread trend. This article further systematically elaborated the enzyme-like activities, matrix, multifunctional properties, catalytic mechanisms and various applications of nanozymes, and the field encounters challenges. Despite notable progress, and requires deeper exploration guide the future research directions. This field harbors broad potential for future developments, promising to impact various aspects of technology and society.
作为将酶样功能与纳米材料独特特性融合在一起的新型多功能材料,纳米酶在材料科学、生物科学等多个跨学科研究领域取得了重大进展。本文首次采用文献计量学方法对全球纳米酶研究进行深入的统计分析,并展示了研究进展、热点和趋势。本文利用来自 Web of Science Core Collection 数据库的数据,全面检索了 2004 年至 2024 年的出版物。不同国家对纳米酶研究的浓厚兴趣表明了这一趋势正在不断增长和普及。本文还系统地阐述了纳米酶的酶样活性、基质、多功能特性、催化机制和各种应用,以及该领域面临的挑战。尽管取得了显著的进展,但仍需要更深入的探索来指导未来的研究方向。该领域具有广阔的发展潜力,有望影响技术和社会的各个方面。
J Nanobiotechnology. 2024-11-13
Adv Mater. 2018-12-27
Appl Biochem Biotechnol. 2025-3
ACS Nano. 2024-5-21
Biosens Bioelectron. 2024-11-1
Bioconjug Chem. 2019-4-22
Colloids Surf B Biointerfaces. 2023-1
Biosensors (Basel). 2025-7-7
Int J Mol Sci. 2025-4-9
Bioact Mater. 2024-9-4
Nat Commun. 2024-7-5
ACS Appl Mater Interfaces. 2023-10-11